Literature DB >> 9010982

The SAMOT supportive care programme in southern Italy.

S Mercadante1, G Trizzino.   

Abstract

Since 1988 a palliative care programme has been in development in Palermo, a large town in Southern Italy. The main objective is to provide home palliative care in conditions in which no other facility exists to meet the needs and reduce the distress of terminal cancer patients. This programme has been implemented and extended to other cities and villages in Sicily. A team composed of physicians, nurses, social workers and volunteers looks after patients at home. This model has been recognized as highly effective. The activities, the problems related to the development of such programme, including those concerned with the sociocultural environment and the family doctor, the needs of specific hospital departments, and the scientific and educational activities, are pointed out.

Entities:  

Mesh:

Year:  1997        PMID: 9010982     DOI: 10.1007/bf01681954

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  5 in total

1.  Home palliative care: results in 1991 versus 1988.

Authors:  S Mercadante; G Genovese; J A Kargar; S Maddaloni; S Roccella; L Salvaggio; M T Simonetti
Journal:  J Pain Symptom Manage       Date:  1992-10       Impact factor: 3.612

2.  Home palliative care: the challenge in Palermo.

Authors:  S Mercadante; S Mangione
Journal:  J Palliat Care       Date:  1990       Impact factor: 2.250

3.  Family doctor and palliative care team: 1988 versus 1990.

Authors:  S Mercadante; S Maddaloni; S Roccella; L Salvaggio; M T Simonetti
Journal:  J Palliat Care       Date:  1991       Impact factor: 2.250

4.  Informatics in palliative care.

Authors:  S Mercadante; V Lanza
Journal:  J Pain Symptom Manage       Date:  1994-01       Impact factor: 3.612

5.  Social characteristics of home care patients in southern Italy.

Authors:  S Mercadante; E Meli di Leo; C M Carollo; G Sunseri
Journal:  J Palliat Care       Date:  1993       Impact factor: 2.250

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.